Balyasny Asset Management »

Nrx Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.7M 894k 4.09

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding Nrx Pharmaceuticals

Vanguard Capital Management
Citadel Advisors
Ameriprise Financial
Balyasny Asset Management
AdvisorShares Investments
Commonwealth Equity Services
UBS Group
Geode Capital Management
Susquehanna International
BlackRock
Marshall Wace
Vanguard Fiduciary Trust
Jane Street
Bleakley Financial Group
Hrt Financial

View all funds holding Nrx Pharmaceuticals